PEOPLE'S FORMULA FOR SUCCESS IN LIFE

By: Valiere Alcena, M.D., M.A.C.P

SOME ROOT CAUSES OF THE HIGH INCIDENCE OF STROKES IN AFRICAN AMERICANS
Vol. 8 pp 1-5
Prestige Medical News
January 27, 2009
By: Valiere Alcena, M.D., M.A.C.P

Third World Health Care in a first world country; The Medical Crisis in America and the Health Disparities it causes.
DIRECTIONS TO DOWNLOAD MY ARTICLES
http://www.filefactory.com/file/fdbad2/
Prestige Medical News
March 20, 2008
By: Valiere Alcena, M.D., F.A.C.P.

Rickets Type I- In a Suburban Hospital: An Unusual Presentation
Vol. 7 pp 1-8
Prestige Medical News
March 11, 2008
By: Valiere Alcena, M.D., F.A.C.P.
Meyer Halberstam, M.D.
Rhonda Rubin, M.D.

Rickets Type I- In a Suburban Hospital: An Unusual Presentation

Prostate cancer in black men in the USA-Revised
Prestige Medical News
December 2003

In 2003 220,900 men in the US will be diagnosed with prostate cancer.
The incidence of prostate cancer in African American men is more than twice that of white men.

Prostate cancer in black men in the USA-Revised

Prostate cancer in black men in the USA
Healthy Lifestyles for African-Americans,
June 2003

In 2003 220,900 men in the US will be diagnosed with prostate cancer.
During that same period of time 28,900 men will die of prostate cancer.
The incidence of prostate cancer in African American men is more than twice that of white men.

Prostate cancer in black men in the USA

Prevalence of Iron Overload in African-Americans:
A Primary Care Experience
DIRECTIONS TO DOWNLOAD MY ARTICLES
http://www.filefactory.com/file/aa3f6b/
Prestige Medical News
February 2003
By: Valiere Alcena, M.D., F.A.C.P

Iron overload has historically been thought of as an inherited disease in Caucasian patients and associated with increased iron intake in African patients. African-American patients have been less well studied. We present data from a primary care practice in Westchester County, New York, where we used serum ferritin to screen for iron overload in African-American patients, We present information on disease prevalence and response to treatment among this population, and we note the first reported C282Y mutation among African-American patients.